Impact of Thyroid CT on Detecting Macroscopic Nodal Metastasis in Patients With Papillary Thyroid Microcarcinoma

Objective: To evaluate the impact of adding CT to ultrasound (US) for nodal assessment in patients with papillary thyroid microcarcinoma (PTMC), particularly in those with US-node-negative disease.Materials and Methods: This single-center retrospective study included consecutive patients with PTMC (1 cm on US) who underwent both US and CT for PTMC staging between August 2016 and January 2020, and subsequently underwent surgery including neck dissection.The number of patients with clinical N1 and pathological N1 disease was assessed.The diagnostic performance of US, CT, and combined US + CT (positive if either was positive) for macroscopic lymph node metastasis (LNM) (i.e., metastatic tumor foci >2 mm) was evaluated.Cases with discordant nodal staging between US and CT were identified.The diagnostic utility of CT was also assessed in a subgroup of patients with node-negative findings on US.Results: Among 982 patients (mean age standard deviation, 47.3 11.5 years; 774 female), pathological analysis confirmed cervical LNM in 377 patients, including macroscopic, microscopic, and size-unknown LNM in 187, 175, and 15 patients, respectively.The addition of CT to US improved sensitivity for detecting macroscopic LNM compared to US alone (68.4% 128/187 vs. 26.7%50/187; P < 0.001), while maintaining high specificity despite a significant decrease (90.9% 709/780 vs. 97.2%758/780; P < 0.001).Discordant nodal staging between US and CT regarding macroscopic LNM was observed in 149 cases (15.2% 149/982), with 131 patients (87.9% 131/149) being upstaged by CT.In patients with node-negative US findings, CT detected US-undetected macroscopic LNM in 78 patients (8.7% 78/895) and exhibited a sensitivity of 56.9% (78/137) and specificity of 93.5% (709/758) for macroscopic LNM. Conclusion:The integration of CT with US improved sensitivity for detecting macroscopic LNM in patients with PTMC, identifying those who would otherwise be inappropriately considered candidates for active surveillance based solely on US findings.This may assist in refining patient management.